Accretion Pharmaceuticals launched its IPO on May 14, aiming to raise Rs 29.75 crore through a fresh issue of shares, with the IPO closing on May 16. The Gujarat-based company, which manufactures a range of healthcare products, plans to use the funds for capital expenditure, debt repayment, and working capital.
Lokpal clears Buch of conflict of interest allegations based on Hindenburg report
The Lokpal dismissed complaints against former Sebi chairperson Madhabi Puri Buch, which were based on a Hindenburg Research report, citing a lack of verifiable material.